HKI-272
3144A1-203 / B1891014
Phase 2 small_molecule completed
Quick answer
HKI-272 for Advanced Breast Cancer is a Phase 2 program (small_molecule) at PUMA BIOTECHNOLOGY, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- PUMA BIOTECHNOLOGY, INC.
- Indication
- Advanced Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed